EUVIMEDEUVIMED entdecken
Beobachtungsstudie

What Is the Role of Sex‐Related Differences in the Effectiveness and Safety of Biological Drugs Used in Patients With Severe Asthma?

Corrado Pelaia iD, Alessandro Casarella, Giulia Pelaia, Gianmarco Marcianò, Vincenzo Rania, Lucia Muraca, Erika Cione, Luigi Bianco, Caterina Palleria, Bruno D'Agostino, Daniela Mazzuca, Giovambattista De Sarro und 2 weitere

The Journal of Clinical Pharmacology · 2023

DOI: 10.1002/jcph.2194 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift The Journal of Clinical Pharmacology, 2023. Verfasst von Corrado Pelaia und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, University "Magna Graecia" of Catanzaro, Catanzaro, Italy. Hauptthemen laut MEDLINE: Anti-Asthmatic Agents, Biological Products, Asthma, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biological drugs are used to treat severe asthma with an improvement of clinical symptoms. Data on sex difference of these drugs in patients with severe asthma are sparse. This study aimed to assess the effects of sex‐related differences on biological drugs in patients with severe asthma. In this observational, open‐label, prospective, noncontrolled, single‐center cohort pilot study, we enrolled adult patients aged >18 years diagnosed with severe asthma and not previously treated with biological drugs. The first clinical end point was the statistical difference ( P < .05) in the efficacy of biological drugs evaluated using the asthma control test and spirometry between sexes. The first safety end point was the statistical difference ( P < .05) in developing adverse drug reactions between sexes. We enrolled 74 patients with severe asthma (48 women and 26 men) with a mean age of 59.4 (standard deviation, 11.8) years. The mean forced expiratory volume in 1 second was 6.9 (standard deviation, 13.9) for women and 9.4 (standard deviation, 10.7) for men and improved significantly after the treatment ( P < .01), with no significant differences in sex ( P = .8). Similarly, the asthma control test improved 12 months after the beginning of the treatment without significant differences between men and women ( P = .5). The most common drug used was omalizumab (45.9% of the patients; P < .01) without significant differences between sex ( P > .05). We did not observe the development of adverse drug reactions during the study. In conclusion, in asthmatic patients, sex does not have a role in either the effectiveness or safety of biological drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Asthmatic AgentsBiological ProductsAsthmaDrug-Related Side Effects and Adverse ReactionsAdultHumansFemaleMaleMiddle AgedProspective StudiesSex CharacteristicsPilot ProjectsAntibodies, Monoclonal, HumanizedTreatment Outcome

Stichwörter der Autor:innen

biological drugsefficacysafetysevere asthmasex

Substanzen

Anti-Asthmatic AgentsBiological ProductsAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Department of Health Sciences, University "Magna Graecia" of Catanzaro, Catanzaro, Italy.
  • Department of Primary Care, ASP Catanzaro, Catanzaro, Italy.
  • Department of Pharmacy, Health and Nutritional Sciences, Department of Excellence 2018-2022, University of Calabria, Arcavacata di Rende, Rende, CS, Italy.
  • GalaScreenLaboratories, University of Calabria, Arcavacata di Rende, Rende, CS, Italy.
  • Medifarmagen SRL, University of Catanzaro and Mater Domini University Hospital, Catanzaro, Italy.
  • Operative Unit of Clinical Pharmacology, Mater Domini University Hospital, Catanzaro, Italy.

ORCID-Profile: Corrado Pelaia, Luca Gallelli

Zitieren

APA

Pelaia, C., Casarella, A., Pelaia, G., Marcianò, G., Rania, V., Muraca, L., Cione, E., Bianco, L., Palleria, C., D'Agostino, B., Mazzuca, D., De Sarro, G., Mizio, G. D., & Gallelli, L. (2023). What Is the Role of Sex‐Related Differences in the Effectiveness and Safety of Biological Drugs Used in Patients With Severe Asthma?. The Journal of Clinical Pharmacology. https://doi.org/10.1002/jcph.2194

Vancouver

Pelaia C, Casarella A, Pelaia G, Marcianò G, Rania V, Muraca L, et al. What Is the Role of Sex‐Related Differences in the Effectiveness and Safety of Biological Drugs Used in Patients With Severe Asthma?. The Journal of Clinical Pharmacology. 2023. doi:10.1002/jcph.2194

BibTeX
@article{Pelaia2023,
  author = {Pelaia, Corrado and Casarella, Alessandro and Pelaia, Giulia and Marcianò, Gianmarco and Rania, Vincenzo and Muraca, Lucia and Cione, Erika and Bianco, Luigi and Palleria, Caterina and D'Agostino, Bruno and Mazzuca, Daniela and De Sarro, Giovambattista and Mizio, Giulio Di and Gallelli, Luca},
  title = {What Is the Role of Sex‐Related Differences in the Effectiveness and Safety of Biological Drugs Used in Patients With Severe Asthma?},
  journal = {The Journal of Clinical Pharmacology},
  year = {2023},
  doi = {10.1002/jcph.2194}
}
Kostenlos starten →